Android app on Google Play

Aegis Capital Starts Navidea Biopharmaceuticals (NAVB) at Hold

January 22, 2013 12:14 PM EST Send to a Friend
Get Alerts NAVB Hot Sheet
Price: $1.43 --0%

Rating Summary:
    3 Buy, 2 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 0
Trade NAVB Now!
Join SI Premium – FREE
Earlier, Aegis Capital initiates coverage on Navidea Biopharmaceuticals (NYSE: NAVB) with a Hold. PT $3.00.

NOTE: Burrill started at a Market Outperform today.

For an analyst ratings summary and ratings history on Navidea Biopharmaceuticals click here. For more ratings news on Navidea Biopharmaceuticals click here.

Shares of Navidea Biopharmaceuticals closed at $2.97 yesterday.




You May Also Be Interested In


Related Categories

New Coverage

Add Your Comment